Association of the clinical cell-cycle risk score with metastasis after radiation therapy and identification of men with prostate cancer who can forgo combined androgen deprivation therapy.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jonathan David Tward, Constantine Mantz, Neal D. Shore, Paul Nguyen, Isla Garraway, Carl A Olsson, Steve Pai-hsun Lee, Arthur Hung, R Jonathan Henderson, Stanley L. Liauw, David Raben, Michael D. Fabrizio, Daniel R. Saltzstein, Paul Yonover, Hiram Alberto Gay, Daniel Joseph Albertson, Tatjana Antic, Lauren Lenz, Steven Stone, Todd Cohen
Institutions: University of Utah, Huntsman Cancer Institute, 21st Century Oncology (United States), Carolina Urologic Research Center, Dana-Farber Cancer Institute, Veterans Health Administration, Columbia University Irving Medical Center, VA Long Beach Healthcare System, Oregon Health & Science University, Regional Urology, University of Chicago, Urology of Virginia, Urology San Antonio, Washington University in St. Louis, Myriad Genetics
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Myriad Genetics
OpenAlex ID: W3135219040